Covishield Side Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scientists from Oxford and Cambridge universities have developed a new all-in-one vaccine that can protect humans against a broad range of coronaviruses, including those that are yet to emerge. The research, published in 'Nature Nanotechnology', is based on a new approach called "proactive vaccinology," where scientists build a vaccine before the disease-causing pathogen even emerges.

AstraZeneca's admission of Covishield's potential link to Thrombosis with Thrombocytopenia Syndrome (TTS) has stirred concerns. Despite its rarity, social media debates over vaccine safety persist. Covishield, similar to AstraZeneca's, faces scrutiny, though TTS isn't exclusive to them. Here are all the answers about your doubts related to the recent controversy over AstraZeneca's Covishield.

AstraZeneca's recent disclosure about Covishield's rare but serious side effects has sparked concerns among both medical professionals and the public. This revelation, including the potential link to heart attacks and strokes, has prompted reactions from celebrities like Rashami Desai, Pooja Bhatt, and Gauahar Khan. Their expressions of apprehension on social media platforms highlight broader concerns about vaccine safety.

Bharat Biotech has emphasized the safety of its Covaxin Covid vaccine, stating that it has shown excellent safety records with no vaccine-associated incidents such as blood clots or other serious side effects. The company highlighted that Covaxin was developed with a focus on safety first, followed by efficacy. It mentioned that Covaxin was extensively evaluated in more than 27,000 subjects during its licensure process and has been continuously monitored for safety by the health ministry.

In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.